🇺🇸 Acetylsalicylic Acid + clopidogrel in United States

53 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain Upper — 6 reports (11.32%)
  2. Dizziness — 6 reports (11.32%)
  3. Hypophagia — 6 reports (11.32%)
  4. Abdominal Discomfort — 5 reports (9.43%)
  5. Deafness Transitory — 5 reports (9.43%)
  6. Decreased Appetite — 5 reports (9.43%)
  7. Drug Hypersensitivity — 5 reports (9.43%)
  8. Drug Ineffective — 5 reports (9.43%)
  9. Ear Infection — 5 reports (9.43%)
  10. Feeding Disorder — 5 reports (9.43%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Acetylsalicylic Acid + clopidogrel approved in United States?

Acetylsalicylic Acid + clopidogrel does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Acetylsalicylic Acid + clopidogrel in United States?

Hospital Universitari Vall d'Hebron Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.